InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

Tevogen Inc.

TVGN Clue Score40
United States Fiscal year ends December CIK 0001860871
Add to watchlist

What the insiders did Net selling

Individual transactions

18
Insider
Date
Role
Action
Shares
Price
Amount
Neal Flomenberg
13 Mar 2026
See Remarks
Sell
501
$6.40
$3.21K
Neal Flomenberg
11 Mar 2026
See Remarks
Sell
452
$7.26
$3.28K
Neal Flomenberg
10 Mar 2026
See Remarks
Sell
19
$7.75
$147.25
Ryan H. Saadi
9 Jun 2025
Chief Executive Officer
Sell
1,438,206
$1.23
$1.77M
Neal Flomenberg
12 Mar 2025
See Remarks
Sell
232,968
$1.09
$253.94K
Neal Flomenberg
11 Mar 2025
See Remarks
Sell
70,252
$1.05
$73.76K
Neal Flomenberg
10 Mar 2025
See Remarks
Sell
70,384
$1.09
$76.72K
Neal Flomenberg
7 Mar 2025
See Remarks
Sell
71,273
$1.14
$81.25K
Neal Flomenberg
6 Mar 2025
See Remarks
Sell
88,519
$1.10
$97.37K
Neal Flomenberg
5 Mar 2025
See Remarks
Sell
110,659
$1.21
$133.90K
Neal Flomenberg
4 Mar 2025
See Remarks
Sell
14,639
$1.28
$18.74K
Neal Flomenberg
17 Oct 2024
See Remarks
Sell
1,078,600
$1.62
$1.75M
Kirti Desai
12 Jun 2024
Chief Financial Officer
Buy
3,000
$0.82
$2.46K
Ryan H. Saadi
5 Jun 2024
Chief Executive Officer
Buy
2,607
$0.77
$2.00K
Corbin Capital Partners, L.P.
17 Jul 2023
10% owner
Sell indirect
1,716,800
$10.68
$18.34M
Corbin Capital Partners, L.P.
17 Jul 2023
10% owner
Sell indirect
603,200
$10.68
$6.44M
Semper Paratus Sponsor LLC
7 Jun 2023
10% owner
Sell
8,988,889
$1.00
$8.99M
Semper Paratus Sponsor LLC
8 Nov 2021
10% owner
Buy
1,300,000
—
no price

What was left out

Form 4 filings counted 50
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 15
Transactions with no price 1
Shares from compensation/vesting 221,567,211
History held since 8 Nov 2021